M26-326: ABBV-253 in Adults With Advanced Solid Tumors
Sponsor: AbbVie Deutschland GmbH & Co. KG
Phase:
Disease: Advanced solid tumors
EU trial number: 2026-526097-17-00
Population: Adults with advanced solid malignancies enrolled in a study evaluating investigational ABBV-253.
Register Investigator Interest
Interested in offering this trial to suitable patients?